Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, the FDA issued a warning letter to Blue Ridge Silver on February 5, 2019, regarding dietary supplement products. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's dietary supplement regulatory authority, though the specific issuing office is not identified in this metadata. To understand the actual compliance issues cited, the complete warning letter would need to be reviewed.